Table 3.

CDR in NIH and current validation cohorts

	% CDR (No. pts/total No.)
MRI Suspicion	NIH		Validation
Overall participant level:	54.4	(55/101)	62.9	(66/105)
Low	32.5	(12/43)	47.5	(19/40)
Moderate/high	74.1	(43/58)	72.3	(47/65)
Fusion only participant level:	43.6	(44/101)	50.5	(53/105)
Low	14.0	(6/43)	32.5	(13/40)
Moderate/high	65.5	(38/58)	61.5	(40/65)
12-Core only participant level:	43.6	(44/101)	48.6	(51/105)
Low	18.6	(8/43)	35.0	(14/40)
Moderate/high	62.1	(36/58)	56.9	(37/65)
Target lesion level:	29.0	(76/262)	48.8	(99/203)
Low	14.6	(23/158)	32.6	(28/86)
Moderate/high	50.0	(53/106)	60.7	(71/117)
Core positivity:
12-Core	11.7	(148/1,260)	12.5	(157/1,260)
Targeted biopsy	20.6	(108/524)	37.9	(154/406)